Advanced Micro Incision Glaucoma Surgery (istent) For the First Time in India at Shree Ramkrishna Netralaya, Thane, Mumbai and Navi Mumbai

Mumbai (Maharashtra) [India], October 22: Shree Ramkrishna Netralaya is pleased to bring istent, and istent inject by Glaukos, the USA for the first time in India. This is the world’s smallest medical device known to be implanted in the human body.

Glaucoma, a sneak thief of sight that Affects 3 in every 100 people across the globe. Glaucoma genes are passed from one generation to another. These altered genes change the constitution of the trabecular meshwork, an area in the front part of the eye through which fluid inside the eye can flow out. This causes blockage of water (aqueous humor) inside the eye, which leads to raised pressure inside the eye, causing damage to the optic nerve.

Dr. Nitin Deshpande of Shree Ramkrishna Netralaya, on the occasion of launch functions, said, “Glaucoma being the 3rd largest cause of blindness in India, with almost 12 million diagnosed patients, we in Shree Ramakrishna Eye Hospital, is committed towards adopting the latest innovation in the field of glaucoma, to ensure world-class patient management and preserving vision till death.”

He further said that “iStent & iStent inject, the latest global innovation by Glaukos Corporation, USA, has been implanted in 3 patients for the first time in India, in our institute. It’s a micro-invasive glaucoma surgery procedure, which not only helps in managing glaucoma effectively and safely but also helps in fighting the key issue of non-adherence to current medication (eye drops), the key reason for glaucoma progression in 53% of treated patients. Since glaucoma is asymptomatic, the damage is already advanced once the patient realizes that he has visual problems.

Once this device is entangled in trabecular meshwork by a skilled surgeon, it increases the outflow of eye fluid (aqueous Humor) which restores the balance of pressure inside the eye, preventing further damage to the Optic Nerve.”

There are multiple advantages to this new generation of glaucoma surgery:

  • It can be inserted through micro-incision, there is minimal injury to the eye
  • This device can be implanted during routine cataract surgery, preventing the need for additional cuts
  • The use of surgical grade titanium and a proven track record makes this surgery safe for the eye.

Shree Ramkrishna Netralaya is a recipient of the prestigious full NABH accredited eye institute in Thane, Mulund and Navi Mumbai. Its well-equipped glaucoma department is providing world-class Glaucoma care at an affordable cost for over 15 years. We are committed to providing compassionate eye care to all under one roof.

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

Block Beats & Biitca Coin Present Hello Jackpot launching Worldwide on 25/05/2022

May 20: According to DR.SAHIL KADARI, CEO/CMD/Founder of Block Beats Company, blockchain represents the future of the next generation and one of the best investment prospects of our time. He is still investigating the applications and development potential of blockchain technology. He has also received several honours, including the Nelson Mandela Award, Indian Iconic Business […]

Read More
Business

Six Times Failed Revision Hip Replacement Surgery of a Ghana patient performed successfully at Krishna Shalby Hospital, Ahmedabad by World-renowned Joint Replacement Surgeon Dr Vikram Shah

Shalby Team of Doctors sitting from right to left Dr Vikram Shah, Dr J A Pachore, Dr Amish Kshtriya. Standing – Dr Pranay Gujjar May 20: A six times failed hip replacement surgery of a Ghana patient was successfully performed by Dr Vikram Shah, world-renowned joint replacement surgeon, at Krishna Shalby Hospital in Ahmedabad. Besides […]

Read More
Business

Corporate Professionals managing to acquire 26% stake in Advik Capital for Rs 23.75 cr

New Delhi (India), May 20: Corporate Professionals Capital Private Limited is managing to acquire a significant stake in Advik Capital Limited (ACL), the company said in a regulatory filing on 18th May. According to the company filing, Corporate professionals managed to buy 5,72,50,253 equity shares with a face value of Re 1 each at a […]

Read More